Location History:
- Malden, MA (US) (2004 - 2008)
- Beverly, MA (US) (2010)
- Southborough, MA (US) (2018 - 2022)
Company Filing History:
Years Active: 2004-2022
Title: Yanming Frank Wang: Innovator in Pharmaceutical Composition
Introduction
Yanming Frank Wang is a notable inventor based in Beverly, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of excessive lactate production and short telomere disorders. With a total of 5 patents to his name, Wang's work is characterized by innovative approaches to complex medical issues.
Latest Patents
Wang's latest patents include a pharmaceutical composition for treating excessive lactate production and acidemia. This invention discloses pharmaceuticals that include glutamate, aspartate, BCAA, pyruvate, malate, oxaloacetate, α-ketoglutarate, AST, ALT, PLP, MDH, GPDH, Lodoxamite, and Oxamate. The mechanism of action involves inhibiting LDH and enhancing malate/aspartate shuttle activity. Another significant patent focuses on compositions and methods for the treatment of short telomere disorders. This invention outlines methods that utilize known compounds and pharmaceutical compositions, specifically administering an effective amount of at least one lithium compound or a pharmaceutically acceptable salt thereof to treat the disorder.
Career Highlights
Throughout his career, Yanming Frank Wang has worked with various companies, including Prescient Pharma, LLC. His innovative contributions have positioned him as a key figure in pharmaceutical research and development.
Collaborations
Wang has collaborated with notable professionals in his field, including Pavel Idelevich. These partnerships have further enhanced his research and development efforts.
Conclusion
Yanming Frank Wang is a distinguished inventor whose work in pharmaceuticals has the potential to significantly impact medical treatments. His innovative patents reflect a deep understanding of complex biological processes and a commitment to advancing healthcare solutions.